BEIJING, Jun。 5 (Xinhua) -- Zhejiang Starry Pharmaceutical Co., Ltd (603520.SH) announced that it planned to acquire a 100 percent stake in Hisyn Pharmaceutical Co. for about 850 million yuan, the Xinhua-run Shanghai Securities News reported on Monday.
In 2018-2020, Hisyn Pharmaceutical's annual net profit was expected to be 43.746 million yuan, 48.699 million yuan and 63.995 million yuan, respectively.
According to the report, shares of Zhejiang Starry Pharmaceutical have resumed trading on Wednesday. (Edited by Yang Yifan, yangyifan@xinhua.org)